Position in ALKS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$219,811,343
+$59,900,059 QoQ
Shares Held
4,194,873
-7.2% QoQ
Ownership
2.50%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#9
of 421 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 88%
Shared 9%
None 3%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
25,417,271 | $625,519,037 | |
| 2 | VTRS |
Viatris Inc
|
29,970,094 | $475,925,092 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
527,904 | $286,034,221 | |
| 4 | ALKS |
Alkermes plc.
This page
|
4,194,873 | $219,811,343 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
1,466,260 | $162,666,882 | |
| 6 | ZTS |
Zoetis Inc.
|
2,173,278 | $156,171,754 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
2,661,291 | $125,799,224 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
732,877 | $123,519,088 |
All Filings in ALKS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,811,343 | 4,194,873 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $159,911,284 | 4,522,378 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $123,469,665 | 4,412,783 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $110,939,880 | 3,697,996 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $88,594,782 | 3,096,637 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $98,762,983 | 2,991,005 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $86,841,047 | 3,019,508 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $80,913,685 | 2,890,807 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $69,504,687 | 2,884,012 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $68,026,177 | 2,512,973 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $66,664,628 | 2,403,195 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $64,786,455 | 2,312,976 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $68,822,031 | 2,198,787 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $61,057,339 | 2,165,922 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $56,132,726 | 2,148,210 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $46,224,839 | 2,070,078 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $62,982,938 | 2,114,231 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $56,239,308 | 2,137,564 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $50,818,354 | 2,184,796 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $63,922,653 | 2,072,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $43,696,650 | 1,782,082 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $24,217,742 | 1,296,453 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $18,072,705 | 905,900 | Shares | Defined | 2021-03-08 | |
| 2020-06-30 | $15,411,015 | 793,973 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $10,523,283 | 729,770 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||